These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

Wegovy and semaglutide-based diabetes therapy Ozempic – which grew 12% to DKK 33.85 billion in the fourth quarter – have been the driving force behind Novo Nordisk's sector-beating growth ...

Heartseed Inc. and Novo Nordisk - in partnership since June 2021 - have announced that the first patient has been successfully dosed in a clinical study with HS-001, a cell therapy designed to ...

CARTERVILLE, Mo. — A new business means the beginning of a new opportunity for Carterville. Rachel Maddow breaks down new ...

Pope Francis is in critical condition in the hospital due to a respiratory crisis while recovering from double pneumonia. The ...